Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IOBENGUANE I-123 for Neuroblastoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where IOBENGUANE I-123 was used for Neuroblastoma.

Most Reported Side Effects for IOBENGUANE I-123

Side Effect Reports % Deaths Hosp.
No adverse event 38 51.4% 0 0
Drug ineffective 19 25.7% 0 1
Radioisotope scan abnormal 19 25.7% 0 0

Other Indications for IOBENGUANE I-123

Diagnostic procedure (30) Product used for unknown indication (24) Phaeochromocytoma (9) Paraganglion neoplasm (8)

Other Drugs Used for Neuroblastoma

CYCLOPHOSPHAMIDE (1,109) ETOPOSIDE (1,061) DOXORUBICIN (725) CARBOPLATIN (671) VINCRISTINE (668) CISPLATIN (633) MELPHALAN (495) TOPOTECAN (443) DINUTUXIMAB (354) BUSULFAN (252)

Related Pages

IOBENGUANE I-123 Full Profile All Neuroblastoma Drugs IOBENGUANE I-123 Demographics IOBENGUANE I-123 Timeline